Concepedia

Alyson Haslam

AH

44

Publications

2.7K

Citations

20

H-Index

2011

Active since

Affiliations

University of California, San Francisco(Current)

University Hospital of Geneva

Oregon Health & Science University

University of Georgia

Oklahoma State University Center for Health Sciences

Alyson Haslam is an author at University of California, San Francisco specializing in medicine, public health, and clinical trials.

ORCID

Top concepts

Publications per year

2011–2025

44

Publications

44

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Alyson Haslam, Vinay Prasad · JAMA Network Open · 2019 · 1.4K citations · Full text

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

Alyson Haslam, Jennifer Gill, Vinay Prasad · JAMA Network Open · 2020 · 261 citations · Full text

FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019

Emerson Y. Chen, Alyson Haslam, Vinay Prasad · JAMA Internal Medicine · 2020 · 115 citations · Full text

Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action

Timothée Olivier, Alyson Haslam, Vinay Prasad · JAMA Network Open · 2021 · 110 citations · Full text

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Alyson Haslam, Minki Kim, Vinay Prasad · Annals of Oncology · 2021 · 97 citations · Full text

, , +10

Rows per page

1–5 of 44